Patent · US Active

Method of assessing diabetic nephropathy using CD5 antigen-like

US9146243B2 · kind B2 · utility

2Cited by
0References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 14, 2014
Grant dateSep 29, 2015
Priority date
Expiry dateMay 14, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/50
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.